Barclays (LON:) analyst Steven Valiquette maintained a Buy rating on Anthem Inc on Wednesday, setting a price target of $370, which is approximately 18.09% above the present share price of $313.32.
Valiquette expects Anthem Inc to post earnings per share (EPS) of $0.88 for the fourth quarter of 2020.
The current consensus among 9 TipRanks analysts is for a Strong Buy rating of shares in Anthem, with an average price target of $352.5.
The analysts price targets range from a high of $389 to a low of $330.
In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $31.16 billion and a net profit of $0. The company’s market cap is $77.92 billion.
According to TipRanks.com, Barclays analyst Steven Valiquette is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 1.4% and a 53.33% success rate.
Anthem is one of the largest private health insurance organizations nationwide, providing medical benefits to roughly 40 million medical members. The company offers employer, individual, and government-sponsored coverage plans. Anthem differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Original post: Source link